The Centers for Medicare & Medicaid Services (CMS) will implement a six-month, nationwide data-driven moratorium on new ...

NEW YORK – Apollo-managed funds have entered into separate definitive agreements to acquire Emerald Holding, Inc., which organizes Medtrade, and Questex, with the intention to combine the businesses ...

Both chambers of the North Carolina General Assembly have approved a one‑year extension of the state’s Medicaid rate floor, moving its expiration from June 30, 2026, to June 30, 2027 ...

The American Medical Association (AMA) has announced a collaboration with the University of Colorado Anschutz on a new educational video series to help physicians and medical students provide ...

More than 13 leading respiratory patient, physician and provider organizations applaud the now more than 50 co-sponsors for the Supplemental Oxygen Access Reform (SOAR) Act (H.R. 2902/S.1406), ...

CONSHOCKEN, Pa. – Accendra Health’s overall growth rates during the first quarter were “not where they need to be,” but execs ...

Telemedicine adoption is not significantly associated with changes in visits or spending – overall or across major payer groups – easing concerns about large spending increases, according to a recent ...

Royal Philips has announced that its shareholders have approved all proposals at the recent Annual General Meeting of ...

A former NFL player who owned a marketing company and was the beneficial owner of eight durable medical equipment (DME) companies has been sentenced to 196 months in prison for his role in a yearslong ...

University of Arizona researchers will use a five-year, nearly $14 million award from the Patient-Centered Outcomes Research Institute (PCORI) to support a clinical trial comparing three common treatm ...

CMS has added electronic prior authorization to its Health Tech Ecosystem. The agency says health systems, hospitals, ...

Aurie has announced that the Aurie Reusable No-Touch Intermittent Catheter System has been granted marketing authorization from the U.S. Food and Drug Administration (FDA) through the Class II De Novo ...